BeiGene Ltd. Logo

BeiGene Ltd. (BEIGF)

OTC

Currency in USD
21.95
0.00 (0.00%)

Real-time Data

01:30 PM

Day's Range

21.95
21.95

52 wk Range

15.95
28.45

Overview - BEIGF - BeiGene Ltd.

Key Statistics

Valuation

Enterprise Value

29.39B

P/E (Trailing)

‪51.03‬

PEG Ratio

‪0.39‬

Price / Sales (TTM)

‪5.26‬

Price / Book

‪6.23‬

EV / EBITDA

‪27.42‬

Profitability

Gross Margin

‪89.76%‬

Profit Margin

‪10.69%‬

Operating Margin

‪19.06%‬

Return on Assets

‪7.45%‬

Return on Equity

‪14.66%‬

Ownership

Shares Outstanding

1.46B

Float

1.05B

Held by Insiders

‪13.75%‬

Held by Institutions

‪29.17%‬

Price stats

Beta

‪0.50‬

50-Day Avg

‪21.95‬

200-Day Avg

‪23.57‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 19, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - BEIGF - BeiGene Ltd.

Peers - BEIGF - BeiGene Ltd.

Peer Comparison

Compared with companies in Biotechnology listed on OTC.

Profile Summary - BEIGF - BeiGene Ltd.

About

BeiGene Ltd. is a biotechnology company that specializes in the research, development, and commercialization of innovative cancer therapeutics. The company's primary function is to create life-saving drugs that can effectively address the complex nature of cancer treatment, with a strong focus on developing targeted…

SectorHealthcare
IndustryBiotechnology
Employees11K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.